| Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers E Lim, F Vaillant, D Wu, NC Forrest, B Pal, AH Hart, ML Asselin-Labat, ... Nature medicine 15 (8), 907-913, 2009 | 1620 | 2009 |
| SNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancer ME Askarian-Amiri, J Crawford, JD French, CE Smart, MA Smith, MB Clark, ... Rna 17 (5), 878-891, 2011 | 377 | 2011 |
| Deletion mapping and expression in Escherichia coli of the large genomic segment of a birnavirus AA Azad, MN Jagadish, MA Brown, PJ Hudson Virology 161 (1), 145-152, 1987 | 362 | 1987 |
| ORAI1-mediated calcium influx in lactation and in breast cancer D McAndrew, DM Grice, AA Peters, FM Davis, T Stewart, M Rice, ... Molecular cancer therapeutics 10 (3), 448-460, 2011 | 257 | 2011 |
| Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers JD French, M Ghoussaini, SL Edwards, KB Meyer, K Michailidou, ... The American Journal of Human Genetics 92 (4), 489-503, 2013 | 253 | 2013 |
| Methylome sequencing in triple-negative breast cancer reveals distinct methylation clusters with prognostic value C Stirzaker, E Zotenko, JZ Song, W Qu, SS Nair, WJ Locke, A Stone, ... Nature communications 6 (1), 5899, 2015 | 215 | 2015 |
| Genetic and Histopathologic Evaluation of BRCA1 and BRCA2 DNA Sequence Variants of Unknown Clinical Significance G Chenevix-Trench, S Healey, S Lakhani, P Waring, M Cummings, ... Cancer research 66 (4), 2019-2027, 2006 | 193 | 2006 |
| Constitutional Methylation of the BRCA1 Promoter Is Specifically Associated with BRCA1 Mutation-Associated Pathology in Early-Onset Breast Cancer EM Wong, MC Southey, SB Fox, MA Brown, JG Dowty, MA Jenkins, ... Cancer Prevention Research 4 (1), 23-33, 2011 | 185 | 2011 |
| Involvement of leukemia inhibitory factor and nerve growth factor in the development of dorsal root ganglion neurons M Murphy, K Reid, MA Brown, PF Bartlett Development 117 (3), 1173-1182, 1993 | 177 | 1993 |
| Dynamic interactions between the promoter and terminator regions of the mammalian BRCA1 gene SM Tan-Wong, JD French, NJ Proudfoot, MA Brown Proceedings of the National Academy of Sciences 105 (13), 5160-5165, 2008 | 172 | 2008 |
| Leukemia inhibitory factor (LIF) infusion stimulates skeletal muscle regeneration after injury: injured muscle expresses lif mRNA W Barnard, J Bower, MA Brown, M Murphy, L Austin Journal of the neurological sciences 123 (1-2), 108-113, 1994 | 167 | 1994 |
| A guide for functional analysis of BRCA1 variants of uncertain significance GA Millot, MA Carvalho, SM Caputo, MPG Vreeswijk, MA Brown, M Webb, ... Human mutation 33 (11), 1526-1537, 2012 | 164 | 2012 |
| Osteoblasts display receptors for and responses to leukemia‐inhibitory factor EH Allan, DJ Hilton, MA Brown, RS Evely, S Yumita, D Metcalf, NM Gough, ... Journal of cellular physiology 145 (1), 110-119, 1990 | 161 | 1990 |
| Roles of heterogeneous nuclear ribonucleoproteins A and B in cell proliferation Y He, MA Brown, JA Rothnagel, NA Saunders, R Smith Journal of cell science 118 (14), 3173-3183, 2005 | 159 | 2005 |
| Distinct transcription start sites generate two forms of BRCA1 mRNA CF Xu, MA Brown, JA Chambers, B Griffiths, H Nicolai, E Solomon Human molecular genetics 4 (12), 2259-2264, 1995 | 147 | 1995 |
| Structural organization of the genes for murine and human leukemia inhibitory factor. Evolutionary conservation of coding and non-coding regions. J Stahl, DP Gearing, TA Willson, MA Brown, JA King, NM Gough Journal of Biological Chemistry 265 (15), 8833-8841, 1990 | 138 | 1990 |
| The use of mild trypsinization conditions in the detachment of endothelial cells to promote subsequent endothelialization on synthetic surfaces MA Brown, CS Wallace, CC Anamelechi, E Clermont, WM Reichert, ... Biomaterials 28 (27), 3928-3935, 2007 | 136 | 2007 |
| Pulsatile perfusion bioreactor for cardiac tissue engineering MA Brown, RK Iyer, M Radisic Biotechnology progress 24 (4), 907-920, 2008 | 135 | 2008 |
| Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation M Ghoussaini, SL Edwards, K Michailidou, S Nord, R Cowper-Sal· lari, ... Nature communications 5 (1), 4999, 2014 | 133 | 2014 |
| BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk AB Spurdle, PJ Whiley, B Thompson, B Feng, S Healey, MA Brown, ... Journal of medical genetics 49 (8), 525-532, 2012 | 127 | 2012 |
